USPTO Deadlines
Next Deadline
1208 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2008-11-18)
Due Date
November 18, 2028
Grace Period Ends
May 18, 2029
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Nov 27, 2018 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
Nov 27, 2018 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
Nov 27, 2018 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
Nov 27, 2018 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
Nov 16, 2018 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
Nov 18, 2017 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
Oct 6, 2017 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
Oct 6, 2017 | CORV | 4 | REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED | Loading... |
Mar 30, 2017 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Mar 30, 2017 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Mar 30, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jan 22, 2014 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
Jan 22, 2014 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
Jan 22, 2014 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
Jan 13, 2014 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
Jan 13, 2014 | 815F | I | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | Loading... |
Nov 18, 2008 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Sep 2, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 13, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Jul 30, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Jul 24, 2008 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
Jul 24, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jul 24, 2008 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 24, 2008 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 24, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jul 24, 2008 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jul 7, 2008 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
Jun 27, 2008 | MREI | O | NOTICE OF REINSTATEMENT MAILED | Loading... |
Jun 26, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Jun 25, 2008 | RGRR | O | REINSTATEMENT GRANTED - RESPONSE RECEIVED | Loading... |
Jun 25, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 25, 2008 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 25, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
Apr 25, 2008 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Apr 2, 2008 | FAXX | I | FAX RECEIVED | Loading... |
Apr 2, 2008 | RFRR | I | REQUEST FOR REINSTATEMENT RECEIVED | Loading... |
Feb 15, 2008 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
Feb 15, 2008 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Feb 15, 2008 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
Jan 10, 2008 | IUAF | S | USE AMENDMENT FILED | Loading... |
Jan 10, 2008 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
Jan 9, 2008 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
Jan 2, 2008 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
Jan 2, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 2, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 2, 2007 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
Jun 29, 2007 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
May 25, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
May 25, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 25, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Detailed Classifications
Class 001
Nucleic acid Polymerase Chain Reaction kits comprising of polymerase dNTP mixture and buffer solution for nucleic acid amplification for performing Polymerase Chain Reaction analysis for scientific and research use; nucleic acid Polymerase Chain Reaction kits comprising reagents to quantitate the amount of initial target in nucleic acid amplification reactions for food and agricultural research; nucleic acid reagents used in molecular biological research applications including Polymerase Chain Reaction; nucleic acid amplification reagent kits consisting of nucleic acid polymerase and buffer solutions for scientific and research use; nucleic acid amplification reagents comprising of fluorescent dye reagents and buffer solutions; chemical reagents, namely, buffer solutions, enzymes and dyes for performing Polymerase Chain Reaction analyses including oligonucleotides, buffer solutions, labeled oligonucleotides, deoxynucleosides, and dyes for diagnostic and research use, and kits containing primarily chemicals for performing Polymerase Chain Reaction analyses including oligonucleotides, buffer solutions, labeled oligonucleotides, and deoxynucleosides for scientific and research use; molecular biological kits comprising of fluorescent dye reagents for nucleic acid amplification and sequencing use for other than medical and veterinary purposes; molecular biological kits for synthesizing first strand cDNA comprised of biological samples, agents and reagents, namely, M-MuLV Reverse Transcriptase, RnaseH, dNTP mix and Placental Rnase Inhibitor for scientific and research use
First Use Anywhere:
Apr 23, 2007
First Use in Commerce:
Apr 23, 2007
Class 005
Chemical reagents for medical or veterinary purposes; biological enzyme composition for use as a clinical diagnostic medical reagent; medical diagnostic preparations for pharmaceutical purposes; chemical reagents for medical use, namely, nucleic acid polymerase composition; nucleic acid amplification reagents comprising of fluorescent dye reagents and buffer solutions for medical and medical diagnostic purposes; molecular biological kits comprising of fluorescent dye reagents for nucleic acid amplification and sequencing use for medical and medical diagnostic purposes; molecular biological kits for synthesizing first strand cDNA comprised of biological samples, agents and reagents, namely, M-MuLV Reverse Transcriptase, RnaseH, dNTP mix and Placental Rnase Inhibitor for medical and medical diagnostic purposes
First Use Anywhere:
Apr 23, 2007
First Use in Commerce:
Apr 23, 2007
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005